- Mi, Z., F. A. Holmes, B. Hellerstedt, J. Pippen, R.Collea, A. Backner, J. Bush, H.H. Gallion, A. Wells, J.A. O’Shaughnessy. (2008) “Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.” Anticancer Research 28: 1733-1740.
- Gallion, H. H., H. Piwowar, et al. (2005). “Uterine cancers: heterogeneity of response to chemotherapy ex vivo, Abstract #168.” 2005 Annual Meeting on Women’s Cancer Society of Gynecologic Oncology.
- Kornblith, P., A. Wells, et al. (2003). "In vitro comparison of response of doxorubicin/cyclophosphamide in combination versus use as individual agents in primary breast cancer, Abstract # 223." Journal of Clinical Oncology, 2003 ASCO Annual Meeting Proceedings 22:56.
- Rosenblum, E., J. Mistovich, et al. (2002). “Co-expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor-AB (PCGF-AB) in cultured human astrocytic tumor cells.” Annual Meeting of the American Association for Cancer Research.
- Rosenblum, E. and M. Donovan-Peluso (2002). “In vitro production of angiogenesis factors by cultured human breast tumor cells.” Annual Meeting of the American Association for Cancer Research.
- Kornblith, P. and D. Burholt (2001). “Chemosensitivity Testing.” Tumors of the Pediatric Central Nervous System. R. Keating, J. Goodrich and P. RJ. New York, Thieme.
- Donovan-Peluso, M., E. Rosenblum, et al. (2001). “Matrix-Metalloproteinase-9 (MMP-9), Vascular Endothelial Growth Factor (VEGF), and Angiogenin (ANG) expression in vitro by astrocytic tumor cells, Abstract #3884.” Annual Meeting of the American Association for Cancer Research.
- Donovan-Peluso, M., D. Burholt, et al. (2000). “Vascular Endothelial Growth Factor (VEGF) expression by cultured ovarian tumor cells correlates with chemotherapeutic cytotoxicity, Abstract #1057.” Annual Meeting of the American Association of Cancer Research.
- Schenken, L., E. Rosenblum, et al. (2000). “In vitro production of tumor associated antigens (TAAs) in cultured human ovarian carcinomas: CA 125, CA 15.3, CEA, Abstract #1850.” Annual Meeting of the American Association for Cancer Research.
- Donovan-Peluso, M., D. Burholt, et al. (2000) “Metastatic disease to the central nervous system is responsive to chemotherapeutic agents in vitro.” American Association of Neurological Surgeons 4th Satellite Symposium.
- Donovan-Peluso, M. and E. Rosenblum (2000). “Expression of angiogenesis factors by cultured primary human brain tumor cells.” Annual Meeting of the American Association of Neurological Surgeons/Congress of Neurological Surgeons.
- Donovan-Peluso, M., E. Rosenblum, et al. (1999). Functional urokinase can be measured directly in medium concentrates from cultured tumor cells in vitro. Annual Meeting of the American Association for Cancer Research.
- Van Thiel, D. H., J. Friedlander, et al. (1999). “Chemosensitivity of primary hepatic neoplasms: A new approach to the treatment of difficult tumors.” Annual Meeting of the American Association for the Study of Liver Diseases.
- Burholt, D., W. A. Christopherson, et al. (1999). Chemosensitivity of primary and recurrent ovarian carcinoma cells in tissue culture. Annual Meeting of the American Association for Cancer Research
- Kornblith, P., D. Burholt, et al. (1999). “Patterns of in vitro chemosensitivity responses of primary human meningioma cell cultures, Abstract #1541.” American Association of Neurological Surgeons.
- Kornblith, P., D. Burholt, et al. (1998). “Patterns of in vitro chemosensitivity responses of primary human glioma cell cultures.” American Association of Neurological Surgeons.
- Kornblith, P., G. J. Naus, et al. (1998). “Approach to the analysis of the effects of cisplatinum in primary brain tumor cultures.” Annual Meeting of the American Association for Cancer Research.
- Kornblith, P., D. Burholt, et al. (1998). “Differential response of primary oligodendroglioma cell cultures to nitrosoureas, Abstract.” Annual Meeting of the Association of Neurological Surgeons/Congress of Neurological Surgeons.
- Covelli, M., D. Burholt, et al. (1998). “In vitro chemosensitivity of primary vs. recurrent ovarian carcinoma.” Mid-Atlantic Gynecologic Oncology Society.
- Burholt, D., G. J. Naus, et al. (1998). “Patterns of in vitro response in ovarian cancer.” Annual Meeting of the American Association for Cancer Research.
- Burholt, D., P. Kornblith, et al. (1997). “Differential chemosensitivity responses of glioblastoma cell lines, Abstract #1513.” Annual Meeting of the American Association of Neurological Surgeons.
